Issue Date: September 21, 2015 | Web Date: September 17, 2015
Making Glycoconjugate Vaccines More Uniform And Effective
Glycoconjugate vaccines can spur the body’s immune system to seek out and attack pathogens or cancer cells on the basis of which specific sugar chains decorate those targets. Approved vaccines for conditions such as meningitis and pneumonia work through such sugar-based antigens.
To make glycoconjugate vaccines, scientists nearly always attach the sugars randomly to amino acids in carrier proteins to enhance the carbohydrates’ ability to elicit an immune response.
Now, researchers have used several reactions . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society